12 Oct2015
01 Oct2015
Konica Minolta Acquires Viztek to Enhance Healthcare IT Solution Capabilities
Wayne, NJ, October 1, 2015 – Konica Minolta, Inc. today announced the completed acquisition of Garner, North Carolina based Viztek, LLC, a leading innovative healthcare company, through Konica Minolta Medical Imaging. With this acquisition, Konica Minolta enhances its capabilities to offer comprehensive, end-to-end healthcare IT solutions from image acquisition to physician diagnosis. It also adds to the established strength
01 Jun2015
UltraSPECT to Present Xpress Suite of Safer Imaging Solutions at SNMMI 2015
SNMMI Attendees Invited to Take Part in New “Hot Trot 5K” Run/Walk to Benefit Professional Development of Nuclear Medicine Technologists Auburndale, Mass., June 1, 2015 (SNMMI Booth #517) – UltraSPECT, a provider of the most cost-effective and vendor-neutral low dose and ultra-low-dose nuclear medicine imaging solutions, will present its Xpress suite of value packages at booth #517 during the Society of Nuclear Medicine & Molecular Imaging (SNMMI) annual meeting from June 6-10 in Baltimore, MD. Low dose imaging increases safety for patients and technologists while providing physicians with high-quality images for accurate diagnosis.
28 May2014
20/20 HealthCare Partners Collaborates with Roche to Source and Advance BioTech Innovations
May 28, 2014 – Auburndale, Mass. – 20/20 HealthCare Partners LLC (20/20 HCP), a global investment group focused on early stage medical technology and life science innovation, is pleased to announce an agreement with Roche, in which they will source and identify novel treatments and/or technologies in the biotech arena. These areas include oncology/immuno-oncology, neurology, infectious diseases, inflammation and ophthalmology. The partnership aims to advance any identified technologies by facilitating collaborations or the formation of new life science companies.
19 Mar2008
INVESTMENT IN CORINDUS, INC.
March 19, 2008 — 20/20 HealthCare Partners LLC (Auburndale, MA) is pleased to announce that its portfolio company, Corindus, Inc., closed a B Round investment taken solely by a New York based hedge fund / private equity fund specializing in the health care industry. Corindus will use the financing to enhance its management structure, complete product development and obtain regulatory approvals in the US and Europe.
The initial funding round led by 20/20 HealthCare Partners in September 2005 enabled Corindus to progress from an early stage company through development of a sophisticated, fully functional robotic catheterization system for the CathLab.